1. Home
  2. SNCR vs BWAY Comparison

SNCR vs BWAY Comparison

Compare SNCR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.54

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.97

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
BWAY
Founded
2000
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
337.9M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
SNCR
BWAY
Price
$8.54
$16.97
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
278.6K
59.5K
Earning Date
11-04-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$170,909,000.00
$49,094,000.00
Revenue This Year
$0.30
$330.76
Revenue Next Year
$5.43
$22.24
P/E Ratio
N/A
$54.90
Revenue Growth
0.07
27.08
52 Week Low
$3.98
$7.84
52 Week High
$12.85
$18.18

Technical Indicators

Market Signals
Indicator
SNCR
BWAY
Relative Strength Index (RSI) 78.10 54.82
Support Level $8.45 $16.75
Resistance Level $8.60 $18.18
Average True Range (ATR) 0.25 0.74
MACD 0.37 0.10
Stochastic Oscillator 92.33 69.37

Price Performance

Historical Comparison
SNCR
BWAY

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: